Linaclotide is a 14-amino acid peptide indicated for the treatment of adults with CC and IBS-C; agonist of guanylate cyclase C
CAT No: 10-101-196
Aspartyl Linaclotide is a synthetic peptide derivative that combines the aspartyl residue with the well-characterized guanylate cyclase-C (GC-C) agonist, linaclotide. As a member of the peptide compound class, it features a specific amino acid sequence modification designed to probe structure-activity relationships and enhance functional studies of peptide-receptor interactions. Its unique configuration allows researchers to dissect the influence of N-terminal extensions on the biological and biophysical properties of linaclotide analogs, making it a valuable tool for advancing peptide-based research. The compound's relevance extends to diverse scientific investigations involving peptide engineering, receptor pharmacology, and gastrointestinal signaling pathways.
Peptide Structure-Activity Relationship Studies: Aspartyl Linaclotide is particularly suited for systematic evaluation in structure-activity relationship (SAR) analyses. By introducing an aspartyl residue at the N-terminus, researchers can assess the impact of sequence modifications on peptide conformation, receptor binding affinity, and downstream signaling efficacy. Such studies are instrumental in elucidating the molecular determinants of GC-C agonist potency and selectivity, thereby informing the rational design of next-generation peptide therapeutics and research probes.
Receptor Pharmacology Research: The compound serves as a robust tool in receptor pharmacology, enabling detailed investigations into the activation mechanisms of guanylate cyclase-C. Its structural features provide a means to explore how peptide modifications influence receptor activation, cyclic GMP production, and downstream cellular responses in vitro. These insights are critical for mapping ligand-receptor interactions and for differentiating the pharmacological profiles of peptide analogs within the GC-C agonist class.
Peptide Engineering and Synthesis Validation: Aspartyl Linaclotide is frequently utilized in peptide engineering workflows, where it acts as a reference or test compound for validating synthetic protocols and analytical methodologies. Its defined structure and modification pattern make it ideal for benchmarking peptide synthesis techniques, assessing purification strategies, and optimizing mass spectrometric or chromatographic analyses. Such applications are essential for ensuring the reproducibility and reliability of peptide manufacturing processes in research settings.
Biochemical Assay Development: The compound's well-characterized activity profile allows it to function as a model peptide in the development and optimization of biochemical assays. Researchers leverage its properties to standardize assay conditions, calibrate detection platforms, and validate assay sensitivity and specificity for GC-C agonist studies. This application is particularly valuable in high-throughput screening, where reliable reference compounds are necessary to ensure data quality and comparability across experimental runs.
Peptide Stability and Degradation Studies: Aspartyl Linaclotide also provides a useful system for investigating peptide stability, degradation kinetics, and resistance to proteolytic cleavage. By subjecting the compound to various enzymatic and physicochemical conditions, researchers can gain insights into the factors that govern peptide half-life, metabolic fate, and formulation stability. These findings contribute to the broader understanding of peptide drug design and the development of more robust peptide-based research reagents.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More